Bill Sponsor
House Bill 3832
118th Congress(2023-2024)
Disease X Act of 2023
Introduced
Introduced
Introduced in House on Jun 5, 2023
Overview
Text
Introduced in House 
Jun 5, 2023
About Linkage
Multiple bills can contain the same text. This could be an identical bill in the opposite chamber or a smaller bill with a section embedded in a larger bill.
Bill Sponsor regularly scans bill texts to find sections that are contained in other bill texts. When a matching section is found, the bills containing that section can be viewed by clicking "View Bills" within the bill text section.
Bill Sponsor is currently only finding exact word-for-word section matches. In a future release, partial matches will be included.
Introduced in House(Jun 5, 2023)
Jun 5, 2023
About Linkage
Multiple bills can contain the same text. This could be an identical bill in the opposite chamber or a smaller bill with a section embedded in a larger bill.
Bill Sponsor regularly scans bill texts to find sections that are contained in other bill texts. When a matching section is found, the bills containing that section can be viewed by clicking "View Bills" within the bill text section.
Bill Sponsor is currently only finding exact word-for-word section matches. In a future release, partial matches will be included.
H. R. 3832 (Introduced-in-House)


118th CONGRESS
1st Session
H. R. 3832


To establish a program at BARDA for developing medical countermeasures for viral threats with pandemic potential.


IN THE HOUSE OF REPRESENTATIVES

June 5, 2023

Mrs. Trahan (for herself, Mr. Burgess, Mr. Crenshaw, and Ms. Lee of Nevada) introduced the following bill; which was referred to the Committee on Energy and Commerce


A BILL

To establish a program at BARDA for developing medical countermeasures for viral threats with pandemic potential.

Be it enacted by the Senate and House of Representatives of the United States of America in Congress assembled,

SECTION 1. Short title.

This Act may be cited as the “Disease X Act of 2023”.

SEC. 2. Medical countermeasures for viral threats with pandemic potential.

Section 319L(c)(4) of the Public Health Service Act (42 U.S.C. 247d–7e(c)(4)) is amended—

(1) in subparagraph (D)—

(A) in clause (ii), by striking “; and” and inserting a semicolon;

(B) by redesignating clause (iii) as clause (v); and

(C) by inserting after clause (ii) the following:

“(iii) the identification and development of platform manufacturing technologies needed for advanced development and manufacturing of medical countermeasures for viral families which have significant potential to cause a pandemic;

“(iv) advanced research and development of flexible medical countermeasures against priority respiratory virus families and other respiratory viral pathogens with a significant potential to cause a pandemic, with both pathogen-specific and pathogen-agnostic approaches; and”; and

(2) in subparagraph (F)—

(A) in clause (ii), by striking “; and” at the end and inserting a semicolon;

(B) in clause (iii), by striking the period and inserting “; and”; and

(C) by adding at the end the following:

“(iv) priority virus families and other viral pathogens with a significant potential to cause a pandemic.”.